Treatment Of Sickle Cell Disease

Magbubah Essack (Inventor), Vladimir B. Bajic (Inventor), Aleksandar Radovanovic (Inventor)

Research output: Patent


The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
Original languageEnglish (US)
Patent numberUS9655905B2
StatePublished - Dec 4 2014

Bibliographical note

KAUST Repository Item: Exported on 2019-02-13


Dive into the research topics of 'Treatment Of Sickle Cell Disease'. Together they form a unique fingerprint.

Cite this